These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16938752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 6. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G, Hoffjan S, Mosler K, Schuster A.
    Lung; 2001 Feb; 179(3):185-94. PubMed ID: 11891608
    [Abstract] [Full Text] [Related]

  • 7. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
    Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F, Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group.
    Am J Respir Crit Care Med; 2004 Mar 15; 169(6):719-25. PubMed ID: 14684561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM, McGaw J, Taylor CJ, Everard ML.
    J Cyst Fibros; 2003 Jun 15; 2(2):69-71. PubMed ID: 15463852
    [Abstract] [Full Text] [Related]

  • 11. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan 15; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.
    Saiman L, Mayer-Hamblett N, Campbell P, Marshall BC, Macrolide Study Group.
    Am J Respir Crit Care Med; 2005 Oct 15; 172(8):1008-12. PubMed ID: 16040785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R, Metcalfe C, Wallis C, Bush A.
    Pediatr Pulmonol; 2004 Apr 15; 37(4):305-10. PubMed ID: 15022126
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ.
    Am J Respir Crit Care Med; 1996 Feb 15; 153(2):752-60. PubMed ID: 8564129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.